UB Paderborn / Katalog / Suche / in CDI

IGF-II promoter methylation and ovarian cancer prognosis

Journal of cancer research and clinical oncology, 2007-10, Vol.133 (10), p.713-723

2007

Link zum Volltext

Verfügbarkeit prüfen

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer

Gynecologic oncology, 2006-12, Vol.103 (3), p.990-995

2006

Link zum Volltext

Verfügbarkeit prüfen

Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma

Annals of oncology, 2005-02, Vol.16 (2), p.300-306

2005

Link zum Volltext

Verfügbarkeit prüfen

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

British journal of cancer, 2002-09, Vol.87 (7), p.763-771

2002

Link zum Volltext

Verfügbarkeit prüfen

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines

British journal of cancer, 2005-02, Vol.92 (4), p.634-638

2005

Link zum Volltext

Verfügbarkeit prüfen

Primary “breast‐like” cancer of the vulva: a case report and critical review of the literature

International journal of gynecological cancer, 2006-02, Vol.16 (S1), p.423-428

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1

Journal of clinical oncology, 2009-10, Vol.27 (28), p.4642-4648

2009

Link zum Volltext

Verfügbarkeit prüfen

Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer

Gynecologic oncology, 2004-09, Vol.94 (3), p.685-692

2004

Link zum Volltext

Verfügbarkeit prüfen

Primary “breast-like” cancer of the vulva: a case report and critical review of the literature

International journal of gynecological cancer, 2006-01, Vol.16 (Suppl 1), p.423-428

2006

Link zum Volltext

Verfügbarkeit prüfen

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Targeted oncology, 2015-12, Vol.10 (4), p.583-596

2015

Link zum Volltext

Verfügbarkeit prüfen

Higher Human Kallikrein Gene 4 (KLK4) Expression Indicates Poor Prognosis of Ovarian Cancer Patients

Clinical cancer research, 2001-08, Vol.7 (8), p.2380-2386

2001

Link zum Volltext

Verfügbarkeit prüfen

Prognostic Value of Human Kallikrein 10 Expression in Epithelial Ovarian Carcinoma

Clinical cancer research, 2001-08, Vol.7 (8), p.2372-2379

2001

Link zum Volltext

Verfügbarkeit prüfen

HUMAN KALLIKREINS AS NOVEL SERUM BIOMARKERS IN EPITHELIAL OVARIAN CANCER

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.10-10

2004

Link zum Volltext

Verfügbarkeit prüfen

PEGYLATED LIPOSOMAL DOXORUBICIN AND VINORELBINE COMBINATION IN ADVANCED HEAVILY PRETREATED OVARIAN CANCER: A PHASE II AND PHARMACOKINETIC STUDY

International journal of gynecological cancer, 2004-09, Vol.14 (Suppl 1), p.151-152

2004

Link zum Volltext

Verfügbarkeit prüfen

LIPOSOMAL DOXORUBICIN AND VINORELBINE COMBINATION IN ADVANCED HEAVILY PRETREATED EPITHELIAL OVARIAN CANCER: A PHASE II AND PHARMACOCINETIC STUDY

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.45-46

2003

Link zum Volltext

Verfügbarkeit prüfen

TISSUE HUMAN KALLIKREIN 11 (HK11) EVALUATION

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.11-12

2003

Link zum Volltext

Verfügbarkeit prüfen

HUMAN KALLIKREIN GENE 15 (KLK15) EXPRESSION

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.19-19

2003

Link zum Volltext

Verfügbarkeit prüfen

HUMAN KALLIKREINS (HKS) AS NOVEL SERUM BIOMARKERS IN OVARIAN CANCER

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.19-20

2003

Link zum Volltext

Verfügbarkeit prüfen

INTRATUMORAL T-CELLS AND SELECT TUMOR MICROENVIRONMENT SIGNIFICANTLY PREDICT CLINICAL OUTCOME IN ADVANCED OVARIAN CANCER

International journal of gynecological cancer, 2003-03, Vol.13 (Suppl 1), p.1-2

2003

Link zum Volltext

Verfügbarkeit prüfen

Growth factors in epithelial ovarian cancer

Minerva ginecologica, 2002-02, Vol.54 (1), p.33

2002

Link zum Volltext

Verfügbarkeit prüfen

Expression and prognostic significance in epithelial ovarian cancer

Minerva ginecologica, 2002-02, Vol.54 (1), p.15

2002

Link zum Volltext

Verfügbarkeit prüfen

Chemoresistance in ovarian cancer. State of the art and future prospects

Minerva ginecologica, 1999-12, Vol.51 (12), p.483

1999

Link zum Volltext

Verfügbarkeit prüfen

Hypermethylation of let-7a-3 in Epithelial Ovarian Cancer Is Associated with Low Insulin-like Growth Factor-II Expression and Favorable Prognosis

Cancer research (Chicago, Ill.), 2007-11, Vol.67 (21), p.10117-10122

2007

Link zum Volltext

Verfügbarkeit prüfen

The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer

Breast cancer research and treatment, 2010-04, Vol.120 (3), p.663-669

2010

Link zum Volltext

Verfügbarkeit prüfen

Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II

European Journal of Cancer, 2009-08, Vol.45 (12), p.2212-2218

2009

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

IGF-II promoter methylation and ovarian cancer prognosis

Promoter-specific transcription of insulin-like growth factor-II in epithelial ovarian cancer

Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma

Immunofluorometric quantitation and histochemical localisation of kallikrein 6 protein in ovarian cancer tissue: a new independent unfavourable prognostic biomarker

Paclitaxel, vinorelbine and 5-fluorouracil in breast cancer patients pretreated with adjuvant anthracyclines

Primary “breast‐like” cancer of the vulva: a case report and critical review of the literature

Phase III Trial of Observation Versus Six Courses of Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer in Complete Response After Six Courses of Paclitaxel/Platinum-Based Chemotherapy: Final Results of the After-6 Protocol 1

Methylation of tumor suppressor gene p16 and prognosis of epithelial ovarian cancer

Primary “breast-like” cancer of the vulva: a case report and critical review of the literature

Epidermal Growth Factor Receptor (EGFR) Pathway Biomarkers in the Randomized Phase III Trial of Erlotinib Versus Observation in Ovarian Cancer Patients with No Evidence of Disease Progression after First-Line Platinum-Based Chemotherapy

Higher Human Kallikrein Gene 4 (KLK4) Expression Indicates Poor Prognosis of Ovarian Cancer Patients

Prognostic Value of Human Kallikrein 10 Expression in Epithelial Ovarian Carcinoma

HUMAN KALLIKREINS AS NOVEL SERUM BIOMARKERS IN EPITHELIAL OVARIAN CANCER

PEGYLATED LIPOSOMAL DOXORUBICIN AND VINORELBINE COMBINATION IN ADVANCED HEAVILY PRETREATED OVARIAN CANCER: A PHASE II AND PHARMACOKINETIC STUDY

LIPOSOMAL DOXORUBICIN AND VINORELBINE COMBINATION IN ADVANCED HEAVILY PRETREATED EPITHELIAL OVARIAN CANCER: A PHASE II AND PHARMACOCINETIC STUDY

TISSUE HUMAN KALLIKREIN 11 (HK11) EVALUATION

HUMAN KALLIKREIN GENE 15 (KLK15) EXPRESSION

HUMAN KALLIKREINS (HKS) AS NOVEL SERUM BIOMARKERS IN OVARIAN CANCER

INTRATUMORAL T-CELLS AND SELECT TUMOR MICROENVIRONMENT SIGNIFICANTLY PREDICT CLINICAL OUTCOME IN ADVANCED OVARIAN CANCER

Growth factors in epithelial ovarian cancer

Expression and prognostic significance in epithelial ovarian cancer

Chemoresistance in ovarian cancer. State of the art and future prospects

Hypermethylation of let-7a-3 in Epithelial Ovarian Cancer Is Associated with Low Insulin-like Growth Factor-II Expression and Favorable Prognosis

The circadian gene NPAS2 is a novel prognostic biomarker for breast cancer

Pluripotent factor lin-28 and its homologue lin-28b in epithelial ovarian cancer and their associations with disease outcomes and expression of let-7a and IGF-II

Suchergebnisse filtern